Format

Send to

Choose Destination
J Community Genet. 2018 Oct;9(4):407-410. doi: 10.1007/s12687-018-0367-3. Epub 2018 May 7.

EUROCAT: an update on its functions and activities.

Author information

1
Congenital Anomaly Register & Information Service for Wales (CARIS) Public Health Wales, Swansea, UK. david.tucker2@wales.nhs.uk.
2
Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
3
IMER Registry (Emilia Romagna Registry of Birth Defects), University of Ferrara and Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy.
4
Paediatric Department, Hospital Lillebaelt, Kolding, Denmark.
5
DG Joint Research Centre, Directorate F - Health Consumers and Reference Materials, Ispra, Italy.
6
Institute of Nursing and Health Research, Ulster University, Newtownabbey, UK.
7
Institute of Health and Society, Newcastle University, Newcastle, UK.
8
Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Abstract

This paper provides an outline of the development and growth of EUROCAT, the European network of congenital anomaly registers. In recent years the network has been through a period of transition and change. The Central Register of data has transferred from the Ulster University to the EU Joint-Research-Centre, Ispra, Italy.The benefits of combining data from across Europe, from different populations and countries are described by the uses to which these data can be put. These uses include:. surveillance of anomalies at a local, regional or pan-European level. pharmacovigilance. registration of rare diseasesNew studies and projects are underway, including EUROlinkCAT (a Horizon 2020 funded data-linkage project), promising a fruitful future in further research of congenital anomalies.

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center